tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Compare Spyre Therapeutics (SYRE) vs. Competitors

Compare
494 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Spyre Therapeutics
$32.80
$2.38B
-15.06
46.04%
8 Buy
0 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$15.94
$1.34B
-5.33
104.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$275.74
$7.91B
-21.37
336.64%
14 Buy
0 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$11.38
$1.29B
-14.04
-2.58%
4 Buy
0 Hold
0 Sell
Strong Buy
Oculis Holding
$23.15
$1.32B
-9.19
4.16%
6 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$26.97
$1.61B
-13.86
96.86%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SYRE
Spyre Therapeutics
32.80
12.00
57.69%
EYPT
EyePoint Pharmaceuticals
15.94
8.74
121.39%
PRAX
Praxis Precision Medicines
275.74
209.90
318.80%
SPRY
ARS Pharmaceuticals
11.38
0.02
0.18%
OCS
Oculis Holding
23.15
0.71
3.16%
UPB
Upstream Bio, Inc.
31.66
20.45
182.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts